News - Page 2
Dr Emanuela Costigliola joins Newcells Biotech’s executive team as a Chief Marketing Officer
Emanuela’s extensive career brings a wealth of experience in marketing in the life science and biotechnology industry and a track record of senior leadership roles at some of the…
Read update
Overcoming optimisation hurdles of high-throughput FMT assay
Several hurdles faced by many scientists, when developing assays and models for drug discovery, were highlighted at the 2023 European Respiratory Society (ERS) Congress. Understanding and investigating…
Read update
An insight into R&D at Newcells Biotech with Dr Fiona Leslie, PhD, Lung platform scientist
Can you tell us a little bit about your professional journey and how you made the transition to industry? I have an undergraduate Degree in biomedical science and also completed…
Read update
Mr Terry Pizzie joins Newcells Biotech Board as non-executive director
Terry’s career in the life science industry spans more than 30 years. He was the CEO of Cambridge based Horizon Discovery Plc, a public company listed on the UK…
Read update
Imaging propels our kidney assays to the next level
We recently expanded our imaging capability with the purchase of an ImageXpress Pico high content imaging (HCI) system from Molecular Devices. Since then, our technical teams have been busy…
Read update
Latest Advances in CAR-T Therapy with novel HLA-typed in vitro cell tools
CAR-T Therapy CAR-T Therapy is a form of immunotherapy that harnesses the power of the patient’s immune system to target and eliminate cancer cells. It involves ex-vivo genetic engineering of…
Read update
MPS summit highlights
About the conference: MPS summit The MPS summit is a small but buzzing conference, where scientists from the pharma industry, academia and microchip manufacturers gather to discuss the latest advances…
Read update
3rd ILD Summit Highlights
About the conference : ILD Summit The ILD Summit is a niche industry dedicated conference focussed on advancing therapies for progressive fibrosing interstitial lung diseases (ILD). This year’s conference was the…
Read update
Pulmonary toxicity – a challenge for drug development
Despite the common assumption that adverse drug reactions usually affect the kidney and liver, over 600 medications have been reported to induce lung toxicity.1 Due to the large surface area,…
Read update
ARVO Highlights
About the conference: ARVO The ARVO conference took place in the New Orleans Ernest N. Morial Convention Center. With over 10 000 attendees, the venue was absolutely huge. If you…
Read update
Latest innovation in retina models brings a fully characterised Retina Pigment Epithelium (RPE)
Why develop an RPE model? Retinal pigment epithelium (RPE) cells play a vital role in the retina by forming the outer blood-retinal barrier and maintaining photoreceptor and visual…
Read update
Antibody drug conjugates (ADCs) – the role of in vitro models in safety assessment
One the fastest growing approaches to treat cancer is the use of antibody drug conjugates (ADCs). Since the approval of the first antibody drug conjugate in 2000,…
Read update
